Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Estrone sulfate

From Wikipedia, the free encyclopedia

This article is about estrone sulfate as a hormone. For its use as a medication, seeEstrone sulfate (medication).

Estrone sulfate
Skeletal formula of estrone sulfate
Space-filling model of the estrone sulfate molecule
Names
IUPAC name
17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate
Systematic IUPAC name
(3aS,3bR,9bS,11aS)-11a-Methyl-1-oxo-2,3,3a,3b,4,5,9b,10,11,11a-decahydro-1H-cyclopenta[a]phenanthren-7-yl hydrogen sulfate
Other names
E1S; Oestrone sulfate; Estrone 3-sulfate; Estra-1,3,5(10)-trien-17-one 3-sulfate
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard100.006.888Edit this at Wikidata
EC Number
  • 207-120-4
KEGG
UNII
  • InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1
    Key: JKKFKPJIXZFSSB-CBZIJGRNSA-N
  • C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O
Properties
C18H22O5S
Molar mass350.429 g/mol
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

Estrone sulfate, also known asE1S,E1SO4 andestrone 3-sulfate, is anatural,endogenoussteroid and anestrogen ester andconjugate.[1][2][3]

In addition to its role as a natural hormone, estrone sulfate is used as amedication, for instance inmenopausal hormone therapy; for information on estrone sulfate as a medication, see theestrone sulfate (medication) article.

Biological function

[edit]

E1S itself is biologically inactive, with less than 1% of therelative binding affinity of estradiol for theERα andERβ.[3][4] However, it can betransformed bysteroid sulfatase, also known as estrogen sulfatase, intoestrone, anestrogen.[5] Simultaneously,estrogen sulfotransferases, includingSULT1A1 andSULT1E1, convert estrone to E1S, resulting in anequilibrium between the two steroids in various tissues.[1][5] Estrone can also be converted by17β-hydroxysteroid dehydrogenases into the morepotent estrogenestradiol.[1] E1S levels are much higher than those of estrone and estradiol, and it is thought to serve as a long-lasting reservoir for estrone andestradiol in the body.[1][6][7] In accordance, E1S has been found totransactivate theestrogen receptor at physiologically relevant concentrations.[8][9] This was diminished with co-application ofirosustat (STX-64), asteroid sulfatase inhibitor, indicating the importance of transformation of estrone sulfate into estrone in the estrogenicity of E1S.[8][9]

Unlike unconjugated estradiol and estrone, which arelipophilic compounds, E1S is ananion and ishydrophilic.[10][11][12] As a result of this, whereas estradiol and estrone are able to readily diffuse through thelipid bilayers of cells, E1S is unable to permeate throughcell membranes.[10][11][12] Instead, estrone sulfate is transported into cells in a tissue-specific manner byactive transport viaorganic-anion-transporting polypeptides (OATPs), includingOATP1A2,OATP1B1,OATP1B3,OATP1C1,OATP2B1,OATP3A1,OATP4A1, andOATP4C1, as well as by thesodium-dependent organic anion transporter (SOAT; SLC10A6).[11][12][13][14]

E1S, serving as a precursor and intermediate for estrone and estradiol, may be involved in thepathophysiology ofestrogen-associated diseases includingbreast cancer,benign breast disease,endometrial cancer,ovarian cancer,prostate cancer, andcolorectal cancer.[1][15][16] For this reason,enzyme inhibitors of steroid sulfatase and 17β-hydroxysteroid dehydrogenase and inhibitors of OATPs, which prevent activation of E1S into estrone and estradiol, are of interest in the potential treatment of such conditions.[1][16][15]

Affinities and estrogenic potencies of estrogen esters and ethers at the estrogen receptors
EstrogenOther namesRBATooltip Relative binding affinity (%)aREP (%)b
ERERαERβ
EstradiolE2100100100
Estradiol 3-sulfateE2S; E2-3S?0.020.04
Estradiol 3-glucuronideE2-3G?0.020.09
Estradiol 17β-glucuronideE2-17G?0.0020.0002
Estradiol benzoateEB; Estradiol 3-benzoate101.10.52
Estradiol 17β-acetateE2-17A31–4524?
Estradiol diacetateEDA; Estradiol 3,17β-diacetate?0.79?
Estradiol propionateEP; Estradiol 17β-propionate19–262.6?
Estradiol valerateEV; Estradiol 17β-valerate2–110.04–21?
Estradiol cypionateEC; Estradiol 17β-cypionate?c4.0?
Estradiol palmitateEstradiol 17β-palmitate0??
Estradiol stearateEstradiol 17β-stearate0??
EstroneE1; 17-Ketoestradiol115.3–3814
Estrone sulfateE1S; Estrone 3-sulfate20.0040.002
Estrone glucuronideE1G; Estrone 3-glucuronide?<0.0010.0006
EthinylestradiolEE; 17α-Ethynylestradiol10017–150129
MestranolEE 3-methyl ether11.3–8.20.16
QuinestrolEE 3-cyclopentyl ether?0.37?
Footnotes:a =Relative binding affinities (RBAs) were determined viain-vitro displacement oflabeledestradiol fromestrogen receptors (ERs) generally ofrodentuterinecytosol.Estrogen esters are variablyhydrolyzed into estrogens in these systems (shorter ester chain length -> greater rate of hydrolysis) and the ER RBAs of the esters decrease strongly when hydrolysis is prevented.b = Relative estrogenic potencies (REPs) were calculated fromhalf-maximal effective concentrations (EC50) that were determined viain-vitroβ‐galactosidase (β-gal) andgreen fluorescent protein (GFP)productionassays inyeast expressing humanERα and humanERβ. Bothmammaliancells and yeast have the capacity to hydrolyze estrogen esters.c = The affinities ofestradiol cypionate for the ERs are similar to those ofestradiol valerate andestradiol benzoate (figure).Sources: See template page.

Chemistry

[edit]
See also:List of estrogens,Estrogen ester, andList of estrogen esters

E1S, also known as estrone 3-sulfate or as estra-1,3,5(10)-trien-17-one 3-sulfate, is anaturally occurringestranesteroid and aderivative ofestrone.[17] It is anestrogen conjugate orester, and is specifically the C3sulfateester of estrone.[17] Related estrogen conjugates includeestradiol sulfate,estriol sulfate,estrone glucuronide,estradiol glucuronide, andestriol glucuronide, while related steroid conjugates includedehydroepiandrosterone sulfate andpregnenolone sulfate.

ThelogP of E1S is 1.4.[15]

Biochemistry

[edit]

Biosynthesis

[edit]

E1S is produced viaestrogen sulfotransferases from the peripheralmetabolism of the estrogensestradiol andestrone.[18][19][20] Estrogen sulfotransferases are expressed minimally or not at all in thegonads.[21] In accordance, E1S is not secreted in meaningful amounts from the gonads in humans.[22][18] However, measurable amounts of estrogen sulfates are said to be secreted by the ovaries in any case.[23]

Production rates, secretion rates, clearance rates, and blood levels of major sex hormones
SexSex hormoneReproductive
phase
Blood
production rate
Gonadal
secretion rate
Metabolic
clearance rate
Reference range (serum levels)
Molar concentrationMass concentration
MenAndrostenedione
2.8 mg/day1.6 mg/day2200 L/day2.8–7.3 nmol/L80–210 ng/dL
Testosterone
6.5 mg/day6.2 mg/day950 L/day6.9–34.7 nmol/L200–1000 ng/dL
Estrone
150 μg/day110 μg/day2050 L/day37–250 pmol/L10–70 pg/mL
Estradiol
60 μg/day50 μg/day1600 L/day<37–210 pmol/L10–57 pg/mL
Estrone sulfate
80 μg/dayInsignificant167 L/day600–2500 pmol/L200–900 pg/mL
WomenAndrostenedione
3.2 mg/day2.8 mg/day2000 L/day3.1–12.2 nmol/L89–350 ng/dL
Testosterone
190 μg/day60 μg/day500 L/day0.7–2.8 nmol/L20–81 ng/dL
EstroneFollicular phase110 μg/day80 μg/day2200 L/day110–400 pmol/L30–110 pg/mL
Luteal phase260 μg/day150 μg/day2200 L/day310–660 pmol/L80–180 pg/mL
Postmenopause40 μg/dayInsignificant1610 L/day22–230 pmol/L6–60 pg/mL
EstradiolFollicular phase90 μg/day80 μg/day1200 L/day<37–360 pmol/L10–98 pg/mL
Luteal phase250 μg/day240 μg/day1200 L/day699–1250 pmol/L190–341 pg/mL
Postmenopause6 μg/dayInsignificant910 L/day<37–140 pmol/L10–38 pg/mL
Estrone sulfateFollicular phase100 μg/dayInsignificant146 L/day700–3600 pmol/L250–1300 pg/mL
Luteal phase180 μg/dayInsignificant146 L/day1100–7300 pmol/L400–2600 pg/mL
ProgesteroneFollicular phase2 mg/day1.7 mg/day2100 L/day0.3–3 nmol/L0.1–0.9 ng/mL
Luteal phase25 mg/day24 mg/day2100 L/day19–45 nmol/L6–14 ng/mL
Notes and sources
Notes: "Theconcentration of a steroid in the circulation is determined by the rate at which it is secreted from glands, the rate of metabolism of precursor or prehormones into the steroid, and the rate at which it is extracted by tissues and metabolized. Thesecretion rate of a steroid refers to the total secretion of the compound from a gland per unit time. Secretion rates have been assessed by sampling the venous effluent from a gland over time and subtracting out the arterial and peripheral venous hormone concentration. Themetabolic clearance rate of a steroid is defined as the volume of blood that has been completely cleared of the hormone per unit time. Theproduction rate of a steroid hormone refers to entry into the blood of the compound from all possible sources, including secretion from glands and conversion of prohormones into the steroid of interest. At steady state, the amount of hormone entering the blood from all sources will be equal to the rate at which it is being cleared (metabolic clearance rate) multiplied by blood concentration (production rate = metabolic clearance rate × concentration). If there is little contribution of prohormone metabolism to the circulating pool of steroid, then the production rate will approximate the secretion rate."Sources: See template.

Distribution

[edit]

Whereas free steroids like estradiol arelipophilic and can enter cells viapassive diffusion, steroid conjugates like E1S arehydrophilic and are unable to do so.[24][25] Instead, steroid conjugates requireactive transport viamembrane transport proteins to enter cells.[24][25]

Studies in animals and humans have had mixed findings on uptake of exogenously administered E1S in normal andtumorousmammary glandtissue.[26][27][28][24][25] This is in contrast to substantial uptake of exogenously administered estradiol and estrone by the mammary glands.[26] Another animal study found that E1S wasn't taken up by theuterus but was taken up by theliver, where it washydrolyzed into estrone.[29][26]

Metabolism

[edit]

Theelimination half-life of E1S is 10 to 12 hours.[3] Itsmetabolic clearance rate is 80 L/day/m2.[3]

Ovarian tumors have been found to expresssteroid sulfatase and have been found to convert E1S into estradiol.[30][31] This may contribute to the often elevated levels of estradiol observed in women withovarian cancer.[30][31]

The image above contains clickable links
Description: Themetabolic pathways involved in themetabolism ofestradiol and othernaturalestrogens (e.g.,estrone,estriol) in humans. In addition to themetabolic transformations shown in the diagram,conjugation (e.g.,sulfation andglucuronidation) occurs in the case of estradiol andmetabolites of estradiol that have one or more availablehydroxyl (–OH)groups.Sources: See template page.


Levels

[edit]
Estrogen levels withradioimmunoassay (RIA) aroundmid-cycle during the normalmenstrual cycle in women.[32][33] The vertical dashed line in the center is mid-cycle.

E1S levels have been characterized in humans.[33][34][35] E1S usingradioimmunoassay (RIA) have been reported to be 0.96 ± 0.11 ng/mL in men, 0.96 ± 0.17 ng/mL during thefollicular phase in women, 1.74 ± 0.32 ng/mL during theluteal phase in women, 0.74 ± 0.11 ng/mL in women takingoral contraceptives, 0.13 ± 0.03 ng/mL inpostmenopausal women, and 2.56 ± 0.47 ng/mL in postmenopausal women onmenopausal hormone therapy.[35] In addition, E1S levels inpregnant women were 19 ± 5 ng/mL in the first trimester, 66 ± 31 ng/mL in the second trimester, and 105 ± 22 ng/mL in the third trimester.[35] E1S levels are about 10 to 15 times higher than those of estrone in women.[36]

References

[edit]
  1. ^abcdefRezvanpour A, Don-Wauchope AC (March 2017). "Clinical implications of estrone sulfate measurement in laboratory medicine".Crit Rev Clin Lab Sci.54 (2):73–86.doi:10.1080/10408363.2016.1252310.PMID 27960570.S2CID 1825531.
  2. ^Lobo RA (5 June 2007).Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Academic Press. pp. 768–.ISBN 978-0-08-055309-2.
  3. ^abcdKuhl H (2005)."Pharmacology of estrogens and progestogens: influence of different routes of administration"(PDF).Climacteric.8 (Suppl 1):3–63.doi:10.1080/13697130500148875.PMID 16112947.S2CID 24616324.
  4. ^Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (March 1997)."Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta".Endocrinology.138 (3):863–70.doi:10.1210/endo.138.3.4979.PMID 9048584.
  5. ^abFalcone T, Hurd WW (22 May 2013).Clinical Reproductive Medicine and Surgery: A Practical Guide. Springer Science & Business Media. pp. 5–6.ISBN 978-1-4614-6837-0.
  6. ^Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (11 November 2015).Williams Textbook of Endocrinology (13th ed.). Elsevier Health Sciences. pp. 607–.ISBN 978-0-323-34157-8.
  7. ^Greenblatt JM, Brogan K (27 April 2016).Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention. CRC Press. pp. 198–.ISBN 978-1-4987-0230-0.
  8. ^abBjerregaard-Olesen C, Ghisari M, Kjeldsen LS, Wielsøe M, Bonefeld-Jørgensen EC (January 2016). "Estrone sulfate and dehydroepiandrosterone sulfate: Transactivation of the estrogen and androgen receptor".Steroids.105:50–8.doi:10.1016/j.steroids.2015.11.009.PMID 26666359.S2CID 46663814.
  9. ^abClark BJ, Prough RA, Klinge CM (2018). "Mechanisms of Action of Dehydroepiandrosterone".Dehydroepiandrosterone. Vitamins and Hormones. Vol. 108. pp. 29–73.doi:10.1016/bs.vh.2018.02.003.ISBN 978-0-12-814361-2.ISSN 0083-6729.PMID 30029731.
  10. ^abPurohit A, Woo LW, Potter BV (July 2011)."Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism"(PDF).Mol. Cell. Endocrinol.340 (2):154–60.doi:10.1016/j.mce.2011.06.012.PMID 21693170.S2CID 14296237.
  11. ^abcAfricander D, Storbeck KH (May 2018). "Steroid metabolism in breast cancer: Where are we and what are we missing?".Mol. Cell. Endocrinol.466:86–97.doi:10.1016/j.mce.2017.05.016.PMID 28527781.S2CID 4547808.
  12. ^abcMueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA (October 2015)."The Regulation of Steroid Action by Sulfation and Desulfation".Endocr. Rev.36 (5):526–63.doi:10.1210/er.2015-1036.PMC 4591525.PMID 26213785.
  13. ^Obaidat A, Roth M, Hagenbuch B (2012)."The expression and function of organic anion transporting polypeptides in normal tissues and in cancer".Annu. Rev. Pharmacol. Toxicol.52:135–51.doi:10.1146/annurev-pharmtox-010510-100556.PMC 3257355.PMID 21854228.
  14. ^Karakus E, Zahner D, Grosser G, Leidolf R, Gundogdu C, Sánchez-Guijo A, Wudy SA, Geyer J (2018)."Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6)".Front Pharmacol.9: 941.doi:10.3389/fphar.2018.00941.PMC 6111516.PMID 30186172.
  15. ^abcBanerjee N, Fonge H, Mikhail A, Reilly RM, Bendayan R, Allen C (2013)."Estrone-3-sulphate, a potential novel ligand for targeting breast cancers".PLOS ONE.8 (5) e64069.Bibcode:2013PLoSO...864069B.doi:10.1371/journal.pone.0064069.PMC 3661587.PMID 23717534.
  16. ^abGilligan LC, Gondal A, Tang V, Hussain MT, Arvaniti A, Hewitt AM, Foster PA (2017)."Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy".Front Pharmacol.8: 103.doi:10.3389/fphar.2017.00103.PMC 5339229.PMID 28326039.
  17. ^abElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 900–.ISBN 978-1-4757-2085-3.
  18. ^abLongcope C, Flood C, Tast J (1994). "The metabolism of estrone sulfate in the female rhesus monkey".Steroids.59 (4):270–273.doi:10.1016/0039-128X(94)90112-0.ISSN 0039-128X.PMID 8079382.S2CID 42846339.The source of E1SO4 in humans is from the peripheral conversion of E1 and E2, 6,7 [...] In human females there is little evidence for the ovarian secretion of E1SO4. 7 Since most of our monkeys were ovariectomized, we cannot say that the rhesus ovaries do not secrete E1SO4, but it is probably unlikely.
  19. ^Ruder HJ, Loriaux L, Lipsett MB (1972)."Estrone Sulfate: Production Rate and Metabolism in Man".Journal of Clinical Investigation.51 (4):1020–1033.doi:10.1172/JCI106862.ISSN 0021-9738.PMC 302214.PMID 5014608.
  20. ^Longcope C (1972). "The Metabolism of Estrone Sulfate in Normal Males".The Journal of Clinical Endocrinology & Metabolism.34 (1):113–122.doi:10.1210/jcem-34-1-113.ISSN 0021-972X.PMID 5008222.
  21. ^Hobkirk R (1985). "Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles".Canadian Journal of Biochemistry and Cell Biology.63 (11):1127–1144.doi:10.1139/o85-141.ISSN 0714-7511.PMID 3910206.
  22. ^Strauss JF (2019)."Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction". In Jerome F. Strauss, Robert L. Barbieri (eds.).Yen & Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management (8 ed.). Elsevier Health Sciences. pp. 75–114.doi:10.1016/B978-0-323-47912-7.00004-4.ISBN 978-0-323-58232-2.S2CID 90621016.
  23. ^Brooks, S. C., Horn, L., Pack, B. A., Rozhin, J., Hansen, E., & Goldberg, R. (1980). Estrogen metabolism and function in vivo and in vitro. In Estrogens in the Environment (Vol. 5, pp. 147-167). Elsevier/North Holland New York.
  24. ^abcReed MJ, Purohit A, Woo LW, Newman SP, Potter BV (April 2005)."Steroid sulfatase: molecular biology, regulation, and inhibition".Endocr. Rev.26 (2):171–202.doi:10.1210/er.2004-0003.PMID 15561802.
  25. ^abcGeisler J (September 2003). "Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators".J. Steroid Biochem. Mol. Biol.86 (3–5):245–53.doi:10.1016/s0960-0760(03)00364-9.PMID 14623518.S2CID 23065230.
  26. ^abcPurohit A, Riaz AA, Ghilchik MW, Reed MJ (November 1992). "The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women".Horm. Metab. Res.24 (11):532–6.doi:10.1055/s-2007-1003382.PMID 1452119.S2CID 260167615.
  27. ^Masamura S, Santner SJ, Santen RJ (July 1996). "Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase".J. Steroid Biochem. Mol. Biol.58 (4):425–9.doi:10.1016/0960-0760(96)00065-9.PMID 8903427.S2CID 22100628.
  28. ^Thijssen JH (September 2004). "Local biosynthesis and metabolism of oestrogens in the human breast".Maturitas.49 (1):25–33.doi:10.1016/j.maturitas.2004.06.004.PMID 15351093.
  29. ^Holinka CF, Gurpide E (April 1980). "In vivo uptake of estrone sulfate by rabbit uterus".Endocrinology.106 (4):1193–7.doi:10.1210/endo-106-4-1193.PMID 7358033.
  30. ^abDay JM, Purohit A, Tutill HJ, Foster PA, Woo LW, Potter BV, Reed MJ (2009). "The Development of Steroid Sulfatase Inhibitors for Hormone-Dependent Cancer Therapy".Annals of the New York Academy of Sciences.1155 (1):80–87.Bibcode:2009NYASA1155...80D.doi:10.1111/j.1749-6632.2008.03677.x.ISSN 0077-8923.PMID 19250195.S2CID 25306673.
  31. ^abKirilovas D, Schedvins K, Naessén T, Von Schoultz B, Carlström K (2009). "Conversion of circulating estrone sulfate to 17β-estradiol by ovarian tumor tissue: A possible mechanism behind elevated circulating concentrations of 17β-estradiol in postmenopausal women with ovarian tumors".Gynecological Endocrinology.23 (1):25–28.doi:10.1080/09513590601058333.ISSN 0951-3590.PMID 17484508.S2CID 25115594.
  32. ^Pasqualini JR, Gelly C, Nguyen BL (1990). "Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens".Ann. N. Y. Acad. Sci.595 (1):106–16.Bibcode:1990NYASA.595..106P.doi:10.1111/j.1749-6632.1990.tb34286.x.PMID 2375600.S2CID 26940935.
  33. ^abNuñez M, Aedo AR, Landgren BM, Cekan SZ, Diczfalusy E (November 1977). "Studies on the pattern of circulating steroids in the normal menstrual cycle. 6. Levels of oestrone sulphate and oestradiol sulphate".Acta Endocrinol.86 (3):621–33.doi:10.1530/acta.0.0860621.PMID 579025.
  34. ^Honjo H, Kitawaki J, Itoh M, Yasuda J, Iwasaku K, Urabe M, Naitoh K, Yamamoto T, Okada H, Ohkubo T (1987). "Serum and urinary estrone sulfate during the menstrual cycle, measured by a direct radioimmunoassay, and fate of exogenously injected estrone sulfate".Horm Res.27 (2):61–8.doi:10.1159/000180788.PMID 3653846.
  35. ^abcRanadive GN, Mistry JS, Damodaran K, Khosravi MJ, Diamandi A, Gimpel T, Castracane VD, Patel S, Stanczyk FZ (February 1998)."Rapid, convenient radioimmunoassay of estrone sulfate".Clin. Chem.44 (2):244–9.doi:10.1093/clinchem/44.2.244.PMID 9474019.
  36. ^Cowie AT, Forsyth IA, Hart IC (1980). "Growth and Development of the Mammary Gland".Hormonal Control of Lactation. Monographs on Endocrinology. Vol. 15. pp. 58–145.doi:10.1007/978-3-642-81389-4_3.ISBN 978-3-642-81391-7.ISSN 0077-1015.

Further reading

[edit]
Precursors
Corticosteroids
Glucocorticoids
Mineralocorticoids
Sex steroids
Androgens
Estrogens
Progestogens
Neurosteroids
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Retrieved from "https://en.wikipedia.org/w/index.php?title=Estrone_sulfate&oldid=1316210656"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp